JP

Revvity Sites Globally

Select your location.

*e-commerce not available for this region.

Hong Kong (China) *

Republic of Korea *

Relevance of multiparametric screening to drug discovery efforts

Whitepaper

Relevance of multiparametric screening to drug discovery efforts

Explore how multiparametric screening is advancing drug discovery and development by helping scientists to gain a better understanding of complex diseases.

In this white paper you will learn:

What multiparametric screening is
Why it is important to drug discovery
Why high-content imaging is a valuable tool for multiparametric screening
How our preclinical services team’s capabilities in functional genomic screening and HCI technology can help advance your drug discovery journey

For research use only. Not for use in diagnostic procedures.

To view the full content please answer a few questions

営業担当者から連絡を受けることに同意します。

お名前（名）

お名前（姓）

国

メールアドレス

会社名

郵便番号

勤務先電話番号

職種

By submitting my personal data, I acknowledge that Revvity Inc. and its affiliates (“Company”) will process my personal data provided above consistent with the Company’s Privacy Policy available here.

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Download Resource

Relevance of multiparametric screening to drug discovery efforts

Download Whitepaper